Remy Daroowala

University Of Cape Town
Observatory, WC 7923, South Africa

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 9 publications

Clinical testing of drug treatment shortening in patients with TB using PET/CT imaging of lung lesions.

Clinical testing of drug treatment shortening in patients with TB using PET/CT imaging of lung lesions.

Journal: Science translational medicine

Published: January 07, 2026

PET-CT benchmarked detection and 5-year progression of asymptomatic tuberculosis: a longitudinal, prospective cohort study.

PET-CT benchmarked detection and 5-year progression of asymptomatic tuberculosis: a longitudinal, prospective cohort study.

Journal: The Lancet. Respiratory medicine

Published: July 17, 2025

PET/CT guided tuberculosis treatment shortening: a randomized trial.

PET/CT guided tuberculosis treatment shortening: a randomized trial.

Journal: medRxiv : the preprint server for health sciences

Published: January 13, 2025

Diagnostic Accuracy of Chest X-ray Computer-Aided Detection Software for Detection of Prevalent and Incident Tuberculosis in Household Contacts.

Diagnostic Accuracy of Chest X-ray Computer-Aided Detection Software for Detection of Prevalent and Incident Tuberculosis in Household Contacts.

Journal: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America

Published: April 25, 2024

High resolution imaging and five-year tuberculosis contact outcomes.

High resolution imaging and five-year tuberculosis contact outcomes.

Journal: medRxiv : the preprint server for health sciences

Published: July 18, 2023

A Phase 2A Trial of the Safety and Tolerability of Increased Dose Rifampicin and Adjunctive Linezolid, With or Without Aspirin, for Human Immunodeficiency Virus-Associated Tuberculous Meningitis: The LASER-TBM Trial.

A Phase 2A Trial of the Safety and Tolerability of Increased Dose Rifampicin and Adjunctive Linezolid, With or Without Aspirin, for Human Immunodeficiency Virus-Associated Tuberculous Meningitis: The LASER-TBM Trial.

Journal: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America

Published: July 27, 2022

Study protocol for a phase 2A trial of the safety and tolerability of increased dose rifampicin and adjunctive linezolid, with or without aspirin, for HIV-associated tuberculous meningitis [LASER-TBM].

Study protocol for a phase 2A trial of the safety and tolerability of increased dose rifampicin and adjunctive linezolid, with or without aspirin, for HIV-associated tuberculous meningitis [LASER-TBM].

Journal: Wellcome open research

Published: May 21, 2021

Plasma Pharmacokinetics of High-Dose Oral versus Intravenous Rifampicin in Patients with Tuberculous Meningitis: a Randomized Controlled Trial.

Plasma Pharmacokinetics of High-Dose Oral versus Intravenous Rifampicin in Patients with Tuberculous Meningitis: a Randomized Controlled Trial.

Journal: Antimicrobial agents and chemotherapy

Published: May 11, 2021

Relationship of SARS-CoV-2-specific CD4 response to COVID-19 severity and impact of HIV-1 and tuberculosis coinfection.

Relationship of SARS-CoV-2-specific CD4 response to COVID-19 severity and impact of HIV-1 and tuberculosis coinfection.

Journal: The Journal of clinical investigation

Published: March 01, 2021

Showing 1-9 of 9

Last Updated: 09/26/2026